© 2025 Syngene International Limited. All rights reserved
Accelerate your journey from Sequence to Vial with Syngene’s one-stop biologics CDMO platform – engineered for early-stage biopharma.
Syngene is a global CRDMO offering end-to-end Biologics services for mammalian and microbial systems across modalities and therapeutic areas. We also offer Sterile Fill-Finish and Viral Testing services, making us a one-stop solution for all Biologics requirements – Target to Therapy!
At Syngene, we are committed to incrementally adding new layers of expertise to drive continued innovation. Solving our partners complex research and manufacturing problems, has been the hallmark of our success, and sustainable long-term relationships.
Syngene offers chemical development, formulation, analytical, clinical development, and manufacturing services across small molecules, oligonucleotides, HPAPIs, and performance and specialty materials.
Syngene supports early-phase to late-phase clinical trials required for drug development programs across a wide range of therapeutic areas.
Syngene offers biologics development and manufacturing solutions for both mammalian and microbial systems. We also offer services from our sterile Fill-Finish facility and Viral Testing facility.
Syngene offers integrated and standalone services across the drug discovery continuum, from Target Identification to IND enabling services.
© 2025 Syngene International Limited. All rights reserved